The ongoing research on pioneering drug candidates for the overactive bladder (OAB) aimed to overcome the limitations of currently licensed pharmacotherapies, such as antimuscarinics, 尾3-adrenergic agents, and botulinum neurotoxin, has been reviewed performing a systematic literature review and web ...